Unlock all Features See Plans and Pricing

Serving leading biopharmaceutical companies globally:

McKinsey
Medtronic
Mallinckrodt
Baxter
Moodys
Dow

Last Updated: September 26, 2022

Investigational Drug Information for JZP-110


✉ Email this page to a colleague

« Back to Dashboard

▶ Start for $1
Remove trial restrictions


What is the drug development status for JZP-110?

JZP-110 is an investigational drug.

There have been 11 clinical trials for JZP-110. The most recent clinical trial was a Phase 3 trial, which was initiated on May 1st 2015.

The most common disease conditions in clinical trials are Sleepiness, Narcolepsy, and Disorders of Excessive Somnolence. The leading clinical trial sponsors are Jazz Pharmaceuticals, Concert Pharmaceuticals, and Children's Oncology Group (COG).

There are thirty-nine US patents protecting this investigational drug and two hundred and eighty-one international patents.

Recent Clinical Trials for JZP-110
TitleSponsorPhase
An Open-Label Study of JZP-458 (RC-P) in Patients With Acute Lymphoblastic Leukemia (ALL)/Lymphoblastic Lymphoma (LBL)Children's Oncology Group (COG)Phase 2/Phase 3
An Open-Label Study of JZP-458 (RC-P) in Patients With Acute Lymphoblastic Leukemia (ALL)/Lymphoblastic Lymphoma (LBL)Jazz PharmaceuticalsPhase 2/Phase 3
A Multicenter Study of the Efficacy and Safety of JZP-258 in the Treatment of Idiopathic Hypersomnia (IH) With an Open-label Safety ExtensionJazz PharmaceuticalsPhase 3

See all JZP-110 clinical trials

Clinical Trial Summary for JZP-110

Top disease conditions for JZP-110
Top clinical trial sponsors for JZP-110

See all JZP-110 clinical trials

US Patents for JZP-110

Drugname Patent Number Patent Title Patent Assignee Estimated Expiration
JZP-110 See Plans and Pricing Treatment for obesity Jazz Pharmaceuticals International III Limited (Hamilton, BM) SK Biopharmaceuticals Co., Ltd. (Seoul, KR) See Plans and Pricing
JZP-110 See Plans and Pricing Formulations of (R)-2-amino-3-phenylpropyl carbamate Jazz Pharmaceuticals International III Limited (Hamilton, BM) See Plans and Pricing
JZP-110 See Plans and Pricing Methods for treating attention-deficit/hyperactivity disorder SK Biopharmaceuticals Co., Ltd. (Seongnam-si, Gyeonggi-do, KR) See Plans and Pricing
JZP-110 See Plans and Pricing Treatment of cataplexy Jazz Pharmaceuticals International III Limited (Hamilton, BM) SK Biopharmaceuticals Co., Ltd. (Seoul, KR) See Plans and Pricing
JZP-110 See Plans and Pricing Aminocarbonylcarbamate compounds SK BIOPHARMACEUTICALS CO., LTD. (Seoul, KR) See Plans and Pricing
>Drugname >Patent Number >Patent Title >Patent Assignee >Estimated Expiration

International Patents for JZP-110

Drugname Country Document Number Estimated Expiration Related US Patent
JZP-110 Canada CA2917702 2033-07-18 See Plans and Pricing
JZP-110 China CN105873576 2033-07-18 See Plans and Pricing
JZP-110 China CN110638804 2033-07-18 See Plans and Pricing
JZP-110 Denmark DK3021838 2033-07-18 See Plans and Pricing
JZP-110 European Patent Office EP3021838 2033-07-18 See Plans and Pricing
>Drugname >Country >Document Number >Estimated Expiration >Related US Patent

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

McKinsey
Medtronic
Mallinckrodt
Baxter
Moodys
Dow

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.